Finance

Lists
Why is AARD down ၅.၃၁%?
Dive Deeper
AARD:NASDAQ
Aardvark Therapeutics Inc
၄.၉၉ US$
-၅.၃၁%
(-၀.၂၈) 1D
၅.၀၀ US$
+၀.၂၀% (+၀.၀၁၀)
After hours
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AARD...
Open
၅.၃၇ US$
High
၅.၆၆ US$
Low
၄.၈၈ US$
Mkt. cap
၁၀.၉၂ ကုဋေ
Avg. vol.
၁.၂၃ သိန်း
Volume
၁.၄၈ သိန်း
52-wk high
၁၇.၉၄ US$
52-wk low
၃.၃၅ US$
EPS
-၃.၂၁ US$
Shares outstanding
၂.၁၉ ကုဋေ
No. of employees
၂၈
Open
၅.၃၇ US$
High
၅.၆၆ US$
Low
၄.၈၈ US$
Mkt. cap
၁၀.၉၂ ကုဋေ
Avg. vol.
၁.၂၃ သိန်း
Volume
၁.၄၈ သိန်း
52-wk high
၁၇.၉၄ US$
52-wk low
၃.၃၅ US$
EPS
-၃.၂၁ US$
Shares outstanding
၂.၁၉ ကုဋေ
No. of employees
၂၈
News stories
From web sources and news partners
About Aardvark Therapeutics Inc
CEO-
Employees၂၈
Founded၂၀၁၇
Headquarters-
Sector-
Websiteaardvarktherapeutics.com
Analyst ratings
Based on 7 analysts giving stock ratings to AARD in the past 3 months
Hold
Buy
1
Hold
4
Sell
2
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AARD in the last 3 months.
Highest
Current ၄.၉၉ US$
၆.၀၀ US$ (+၂၀.၂၄%)
Average
၅.၂၅ US$ (+၅.၂၁%)
Lowest
၃.၀၀ US$ (-၃၉.၈၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Abrahams
RBC Capital
Hold
Maintained
၆.၀၀ US$
+၂၀.၂%
09/24/2026
Tazeen Ahmad
Bank of America Securities
Sell
Maintained
-
-
08/14/2026
James Condulis
Stifel Nicolaus
Hold
Reiterated
၆.၀၀ US$
+၂၀.၂%
08/13/2026
Jeet Mukherjee
BTIG
Hold
Maintained
-
-
08/12/2026
Michael Ulz
Morgan Stanley
Sell
Reiterated
၃.၀၀ US$
-၃၉.၉%
08/12/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
08/12/2026
Ram Selvaraju
H.C. Wainwright
Hold
Reiterated
၆.၀၀ US$
+၂၀.၂%
07/20/2026
William Wood
B. Riley Securities
Buy
Maintained
၇.၀၀ US$
+၄၀.၃%
05/15/2026
Tim Anderson
Bank of America Securities
Buy
Reiterated
၁၈.၀၀ US$
+၂၆၀.၇%
05/08/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
၄၅.၀၀ US$
+၈၀၁.၈%
03/02/2026
Leland Gershell
Oppenheimer
Buy
Maintained
၂၁.၀၀ US$
+၃၂၀.၈%
02/27/2026
Last report
၂၀၂၆ ဩ ၁၁
Fiscal period
Q2 2026
EPS / Est. (USD)
-၀.၆၆ US$ / -၀.၈၈ US$
+၂၅.၁၁%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၃၇ ကုဋေ
၁.၄၃ ကုဋေ
၁.၆၆ ကုဋေ
၁.၀၅ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၉၇ သန်း
၄.၄၀ သန်း
၅.၉၀ သန်း
၄.၆၃ သန်း
Operating expense
၁.၇၇ ကုဋေ
၁.၈၇ ကုဋေ
၂.၂၅ ကုဋေ
၁.၅၁ ကုဋေ
Total operating expenses
၁.၇၇ ကုဋေ
၁.၈၇ ကုဋေ
၂.၂၅ ကုဋေ
၁.၅၁ ကုဋေ
Operating income
-၁.၇၇ ကုဋေ
-၁.၈၇ ကုဋေ
-၂.၂၅ ကုဋေ
-၁.၅၁ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၁.၆၃ ကုဋေ
-၁.၇၆ ကုဋေ
-၂.၁၆ ကုဋေ
-၁.၄၄ ကုဋေ
EBT excluding unusual items
-၁.၆၄ ကုဋေ
-၁.၇၆ ကုဋေ
-၂.၁၆ ကုဋေ
-၁.၄၄ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၆၃ ကုဋေ
-၁.၇၆ ကုဋေ
-၂.၁၆ ကုဋေ
-၁.၄၄ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၇၅
-၀.၈၁
-၀.၉၉
-၀.၆၆
Interest and investment income
၁.၃၅ သန်း
၁.၁၂ သန်း
၈.၈၉ သိန်း
၆.၉၅ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၃၅ သန်း
၁.၁၂ သန်း
၈.၈၉ သိန်း
၆.၉၅ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၇၇ ကုဋေ
-၁.၈၇ ကုဋေ
-၂.၂၅ ကုဋေ
-၁.၅၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ